Highlights
About
Microbiome-based Therapeutics
Biomica is a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics for the treatment of immune-mediated and infectious diseases, with specific focus on Immuno-Oncology and GI related disorders.
The company aims to identify and target microbes, metabolites and other microbiome-related components that are key in the etiology of human diseases impacted by the microbiome, using both biological and small-molecule approaches.
Biomica’s discovery and development efforts are powered by PRISM (Predictive, high Resolution, Integrative Selection of Microbes) platform. PRISM is a proprietary metagenomics analysis platform for functional genomics profiling utilizing internal comprehensive databases. Employing Biomica’s drug discovery approach, PRISM combines a profound understanding of the microbiome and its functions and their intricate relations with the human host.
Biomica is a subsidiary of Evogene.
Identity
| Name | Biomica |
|---|---|
| Slug | biomica |
| Type / kind | startup |
| Crunchbase ID | biomica |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoInRgokIDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Rehovot |
| HQ address | Derech Gad Feinstein 13, Rehovot, Israel |
Web & social
| Website | https://www.biomicamed.com |
|---|---|
| Careers page | http://www.biomicamed.com/careers |
| https://www.linkedin.com/company/28646072 |
Classifications
Funding
| Total raised | $37.0M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}